- Canagliflozin for the treatment of type 2 diabetesA Babu
Department of Internal Medicine, Division of Endocrinology, John Stroger Hospital of Cook County, Chicago, Illinois, USA
Drugs Today (Barc) 49:363-76. 2013..Canagliflozin is the first oral SGLT2 inhibitor approved in the U.S. market and it represents a promising approach for the treatment of diabetes in this era of increasing obesity. ..